These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 27898491)

  • 21. Intravenous ketorolac and subarachnoid opioid analgesia in the management of acute postoperative pain.
    Gwirtz KH; Kim HC; Nagy DJ; Young JV; Byers RS; Kovach DA; Li W
    Reg Anesth; 1995; 20(5):395-401. PubMed ID: 8519716
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ondansetron Does Not Reduce Withdrawal in Patients With Physical Dependence on Chronic Opioid Therapy.
    Chu LF; Sun J; Clemenson A; Erlendson MJ; Rico T; Cornell E; Obasi H; Sayyid ZN; Encisco EM; Yu J; Gamble JG; Carroll I; Clark JD
    J Addict Med; 2017; 11(5):342-349. PubMed ID: 28514235
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Postoperative analgesia after radical prostatectomy with high-dose intrathecal morphine and intravenous naloxone: a retrospective review.
    Rebel A; Sloan P; Andrykowski M
    J Opioid Manag; 2009; 5(6):331-9. PubMed ID: 20073407
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The association between psychopathology and placebo analgesia in patients with discogenic low back pain.
    Wasan AD; Kaptchuk TJ; Davar G; Jamison RN
    Pain Med; 2006; 7(3):217-28. PubMed ID: 16712621
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship between endogenous opioid function and opioid analgesic adverse effects.
    Gupta RK; Bruehl S; Burns JW; Buvanendran A; Chont M; Schuster E; France CR
    Reg Anesth Pain Med; 2014; 39(3):219-24. PubMed ID: 24682081
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trait anger and blood pressure recovery following acute pain: evidence for opioid-mediated effects.
    Bruehl S; Chung OY; Burns JW
    Int J Behav Med; 2006; 13(2):138-46. PubMed ID: 16712431
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The combination of low dose of naloxone and morphine in PCA does not decrease opioid requirements in the postoperative period.
    Cepeda MS; Africano JM; Manrique AM; Fragoso W; Carr DB
    Pain; 2002 Mar; 96(1-2):73-9. PubMed ID: 11932063
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Are endogenous opioid mechanisms involved in the effects of aerobic exercise training on chronic low back pain? A randomized controlled trial.
    Bruehl S; Burns JW; Koltyn K; Gupta R; Buvanendran A; Edwards D; Chont M; Wu YH; Qu'd D; Stone A
    Pain; 2020 Dec; 161(12):2887-2897. PubMed ID: 32569082
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The optimal dose of prophylactic intravenous naloxone in ameliorating opioid-induced side effects in children receiving intravenous patient-controlled analgesia morphine for moderate to severe pain: a dose finding study.
    Monitto CL; Kost-Byerly S; White E; Lee CK; Rudek MA; Thompson C; Yaster M
    Anesth Analg; 2011 Oct; 113(4):834-42. PubMed ID: 21890885
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changes in Pain Sensitivity and Pain Modulation During Oral Opioid Treatment: The Impact of Negative Affect.
    Edwards RR; Dolman AJ; Michna E; Katz JN; Nedeljkovic SS; Janfaza D; Isaac Z; Martel MO; Jamison RN; Wasan AD
    Pain Med; 2016 Oct; 17(10):1882-1891. PubMed ID: 26933094
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tolerability, Safety, and Quality of Life with Tapentadol Prolonged Release (PR) Compared with Oxycodone/Naloxone PR in Patients with Severe Chronic Low Back Pain with a Neuropathic Component: A Randomized, Controlled, Open-label, Phase 3b/4 Trial.
    Baron R; Jansen JP; Binder A; Pombo-Suarez M; Kennes L; Müller M; Falke D; Steigerwald I
    Pain Pract; 2016 Jun; 16(5):600-19. PubMed ID: 26554630
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Naloxone infusion and post-hysterectomy morphine consumption: a double-blind, placebo-controlled study.
    Movafegh A; Shoeibi G; Ansari M; Sadeghi M; Azimaraghi O; Aghajani Y
    Acta Anaesthesiol Scand; 2012 Nov; 56(10):1241-9. PubMed ID: 22946762
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Psychiatric Comorbidity Is Associated Prospectively with Diminished Opioid Analgesia and Increased Opioid Misuse in Patients with Chronic Low Back Pain.
    Wasan AD; Michna E; Edwards RR; Katz JN; Nedeljkovic SS; Dolman AJ; Janfaza D; Isaac Z; Jamison RN
    Anesthesiology; 2015 Oct; 123(4):861-72. PubMed ID: 26375824
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Distress Intolerance and Prescription Opioid Misuse Among Patients With Chronic Pain.
    McHugh RK; Weiss RD; Cornelius M; Martel MO; Jamison RN; Edwards RR
    J Pain; 2016 Jul; 17(7):806-14. PubMed ID: 27058161
    [TBL] [Abstract][Full Text] [Related]  

  • 35. OPAL: a randomised, placebo-controlled trial of opioid analgesia for the reduction of pain severity in people with acute spinal pain. Trial protocol.
    Lin CW; McLachlan AJ; Latimer J; Day RO; Billot L; Koes BW; Maher CG
    BMJ Open; 2016 Aug; 6(8):e011278. PubMed ID: 27558901
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship of negative affect and outcome of an opioid therapy trial among low back pain patients.
    Jamison RN; Edwards RR; Liu X; Ross EL; Michna E; Warnick M; Wasan AD
    Pain Pract; 2013 Mar; 13(3):173-81. PubMed ID: 22681407
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expectancy Effects on Conditioned Pain Modulation Are Not Influenced by Naloxone or Morphine.
    France CR; Burns JW; Gupta RK; Buvanendran A; Chont M; Schuster E; Orlowska D; Bruehl S
    Ann Behav Med; 2016 Aug; 50(4):497-505. PubMed ID: 26809850
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantitative sensory tests fairly reflect immediate effects of oxycodone in chronic low-back pain.
    Schliessbach J; Siegenthaler A; Bütikofer L; Vuilleumier P; Jüni P; Arendt-Nielsen L; Curatolo M
    Scand J Pain; 2017 Oct; 17():107-115. PubMed ID: 28850362
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analgesic tolerance without demonstrable opioid-induced hyperalgesia: a double-blinded, randomized, placebo-controlled trial of sustained-release morphine for treatment of chronic nonradicular low-back pain.
    Chu LF; D'Arcy N; Brady C; Zamora AK; Young CA; Kim JE; Clemenson AM; Angst MS; Clark DJ
    Pain; 2012 Aug; 153(8):1583-1592. PubMed ID: 22704854
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An investigation of the ability of oral naloxone to correct opioid-related constipation in patients with advanced cancer.
    Sykes NP
    Palliat Med; 1996 Apr; 10(2):135-44. PubMed ID: 8800821
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.